Each birth reduced the risk of ER+PR+ cancer by 11% (RR per birth = 0.89, 95% CI = 0.84–0.94), and the p value for homogeneity between ER+PR+ versus ER-PR- cancer was less than 0.001 (Figure 1). The gene discussed is PGR; the disease is cancer.